✦ LIBER ✦

Results of combined modality therapy for patients with anal cancer (E7283). An eastern cooperative oncology group study

✍ Scribed by James A. Martenson; Stuart R. Lipsitz; Myrto Lefkopoulou; Paul F. Engstrom; Yogeshwar Y. Dayal; Charles D. Cobau; Martin M. Oken; Daniel G. Hatter

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 505 KB
Volume: 76
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19951115)76:10<1731::aid-cncr2820761009>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of trimetrexate for patie

Phase II trial of trimetrexate for patients with advanced gastric carcinoma : An Eastern Cooperative Oncology Group Study (E1287)

✍ Ramesh K. Ramanathan; Stuart Lipsitz; Robert F. Asbury; Raman Qazi; Bernard R. G 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast

Randomized trial of initial therapy with

Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: Initial and long term results—Eastern Cooperative Oncology Group study E2878

✍ Scott Wadler; Beow Yeap; Steven Vogl; Paul Carbone 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## BACKGROUND. Following surgical debulking, most patients with International Federation of Gynecology and Obstetrics (FIGO) Stage 111 or IV carcinoma of the ovary receive treatment with combination chemotherapy. However, the optimal postsurgical therapy for ovarian carcinoma remains to be defined

Phase II study of carboxyamidotriazole i

Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy : E4896, an Eastern Cooperative Oncology Group study

✍ Janice P. Dutcher; Larry Leon; Judith Manola; David M. Friedland; Bruce Roth; Ge 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Adjuvant chemohormonal therapy with cycl

Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial

✍ Douglass C. Tormey; Robert Gray; Kennedy Gilchrist; Theodore Grage; Paul P. Carb 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

A phase II study of 5-fluorouracil, leuc

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext

A randomized Phase II trial of echinomyc

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)

✍ Alex Y. Chang; KyungMann Kim; Hélène Boucher; Philip Bonomi; James A. Stewart; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: Patients with metastatic nonsmall cell lung carcinoma (nsclc) usually have a poor prognosis. a chemotherapy regimen containing cisplatin is commonly used for symptom palliation. echinomycin is a potent bifunctional intercalator of double-strand dna; trimetrexate is a new derivative o